Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 2 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioXcel Therapeutics Inc | BTAI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.75 | 04:39:50 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.75 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 2 | - | 1.91 - 29.56 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 04:44:54 | 2 | $ 2.75 | USD |
BioXcel Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 80.5M | 29.27M | - | 1.38M | -179.05M | -6.12 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioXcel Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTAI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.58 | 3.099 | 2.55 | 2.78 | 537,351 | 0.17 | 6.59% |
| 1 Month | 2.69 | 3.099 | 2.55 | 2.78 | 464,846 | 0.06 | 2.23% |
| 3 Months | 2.59 | 4.17 | 1.91 | 2.85 | 1,615,930 | 0.16 | 6.18% |
| 6 Months | 3.04 | 5.6199 | 1.91 | 3.28 | 2,182,465 | -0.29 | -9.54% |
| 1 Year | 19.00 | 29.56 | 1.91 | 6.04 | 2,071,019 | -16.25 | -85.53% |
| 3 Years | 35.06 | 38.9994 | 1.91 | 10.29 | 956,674 | -32.31 | -92.16% |
| 5 Years | 10.27 | 74.89 | 1.91 | 16.64 | 728,651 | -7.52 | -73.22% |
BioXcel Therapeutics Description
| BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. |
